Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
Serra R, Giunta EF, Schepisi G, Brighi N, Montanari D, Lolli C, Bleve S, Piras M, Palmieri G, Scartozzi M, Paliogiannis P, De Giorgi U. Serra R, et al. Among authors: bleve s. Expert Rev Anticancer Ther. 2024 Dec;24(12):1221-1227. doi: 10.1080/14737140.2024.2445152. Epub 2024 Dec 25. Expert Rev Anticancer Ther. 2024. PMID: 39716888 Review.
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.
Giunta EF, Caroli P, Scarpi E, Altavilla A, Rossetti V, Marini I, Celli M, Casadei C, Lolli C, Schepisi G, Bleve S, Brighi N, Cursano MC, Paganelli G, Matteucci F, De Giorgi U. Giunta EF, et al. Among authors: bleve s. Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):326-334. doi: 10.1007/s00259-024-06887-4. Epub 2024 Aug 29. Eur J Nucl Med Mol Imaging. 2024. PMID: 39207484 Free PMC article.
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study.
Casadei C, Scarpi E, Conteduca V, Gurioli G, Cursano MC, Brighi N, Lolli C, Schepisi G, Basso U, Fornarini G, Bleve S, Farolfi A, Altavilla A, Burgio SL, Giunta EF, Gianni C, Filograna A, Ulivi P, Olmos D, Castro E, De Giorgi U. Casadei C, et al. Among authors: bleve s. Eur Urol Open Sci. 2024 Feb 7;61:44-51. doi: 10.1016/j.euros.2024.01.015. eCollection 2024 Mar. Eur Urol Open Sci. 2024. PMID: 38384439 Free PMC article.
Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors.
Urbini M, Bleve S, Schepisi G, Menna C, Gurioli G, Gianni C, De Giorgi U. Urbini M, et al. Among authors: bleve s. Int J Mol Sci. 2023 Nov 28;24(23):16872. doi: 10.3390/ijms242316872. Int J Mol Sci. 2023. PMID: 38069192 Free PMC article. Review.
Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial.
Brighi N, Conteduca V, Gurioli G, Scarpi E, Cursano MC, Bleve S, Lolli C, Schepisi G, Casadei C, Gianni C, Ulivi P, De Giorgi U. Brighi N, et al. Among authors: bleve s. ESMO Open. 2023 Dec;8(6):102036. doi: 10.1016/j.esmoop.2023.102036. Epub 2023 Oct 20. ESMO Open. 2023. PMID: 37866028 Free PMC article.
20 results